Información de Insulet Corp, dividendo de Insulet Corp, actividades de los accionistas y más

Más Datos de Insulet Corp Compañía

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Información de Insulet Corp



Símbolo de cotizaciónPODD

Nombre de la empresaInsulet Corp

Fecha de salida a bolsaMay 15, 2007

Director ejecutivoMs. Ashley Mcevoy

Número de empleados3900

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 15

Dirección100 Nagog Park

CiudadACTON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01720-3440

Teléfono19786007000

Sitio Webhttps://www.omnipod.com

Símbolo de cotizaciónPODD

Fecha de salida a bolsaMay 15, 2007

Director ejecutivoMs. Ashley Mcevoy

Ejecutivos de Insulet Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

--

Mr. Prem Singh

Senior Vice President - Global Operations

3.56K

-16.16%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Por negocioUSD

Nombre

Ganancia

Proporción

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

463.30M

71.38%

All Other

185.80M

28.62%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Estadísticas de accionistas

Actualizado: mar., 19 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Otro

60.68%

Accionistas

Proporción

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Otro

60.68%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

64.61%

Investment Advisor/Hedge Fund

23.75%

Hedge Fund

5.78%

Research Firm

2.96%

Pension Fund

2.15%

Sovereign Wealth Fund

1.60%

Bank and Trust

1.22%

Individual Investor

0.30%

Private Equity

0.09%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

1522

71.86M

102.08%

-3.62M

2025Q2

1541

72.80M

103.47%

-3.81M

2025Q1

1569

72.82M

103.50%

-3.52M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

8.68M

12.33%

+38.89K

+0.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

6.86M

9.74%

-271.19K

-3.80%

Jun 30, 2025

Capital Research Global Investors

4.74M

6.73%

-1.34M

-22.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.35M

6.18%

-13.40K

-0.31%

Jun 30, 2025

State Street Investment Management (US)

3.06M

4.34%

+32.74K

+1.08%

Jun 30, 2025

Baillie Gifford & Co.

2.14M

3.03%

-115.69K

-5.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.93M

2.74%

+58.31K

+3.12%

Jun 30, 2025

ClearBridge Investments, LLC

1.54M

2.18%

+56.63K

+3.83%

Jun 30, 2025

American Century Investment Management, Inc.

1.31M

1.86%

+157.07K

+13.63%

Jun 30, 2025

Fidelity International

1.13M

1.61%

-155.38K

-12.09%

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

Langar Global HealthTech ETF

6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.97%

Goldman Sachs Future Health Care Equity ETF

4.91%

Global X HealthTech ETF

4.42%

Fidelity Digital Health ETF

4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

3.4%

Congress SMid Growth ETF

2.99%

iShares U.S. Medical Devices ETF

2.74%

iShares Health Innovation Active ETF

2.64%

FT Raymond James Multicap Growth Equity ETF

2.54%

Langar Global HealthTech ETF

Proporción6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción4.97%

Goldman Sachs Future Health Care Equity ETF

Proporción4.91%

Global X HealthTech ETF

Proporción4.42%

Fidelity Digital Health ETF

Proporción4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporción3.4%

Congress SMid Growth ETF

Proporción2.99%

iShares U.S. Medical Devices ETF

Proporción2.74%

iShares Health Innovation Active ETF

Proporción2.64%

FT Raymond James Multicap Growth Equity ETF

Proporción2.54%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos